Neuropathix, Inc.
CIK 1615999 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Neuropathix, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 17, 2025 | D | 0001615999-25-000003 |
| Oct 20, 2023 | REVOKED | 9999999997-23-004556 |
| Aug 12, 2022 | NT 10-Q | 0001607062-22-000498 |
| Jun 13, 2022 | 4 | 0001607062-22-000413 |
| Jun 2, 2022 | 4 | 0001607062-22-000403 |
| May 23, 2022 | 10-Q | 0001607062-22-000388 |
| May 16, 2022 | NT 10-Q | 0001607062-22-000349 |
| Apr 15, 2022 | 10-K | 0001607062-22-000284 |
| Mar 31, 2022 | NT 10-K | 0001607062-22-000220 |
| Mar 25, 2022 | 8-K | 0001607062-22-000204 |
| Jan 7, 2022 | 4 | 0001607062-22-000004 |
| Nov 12, 2021 | 10-Q | 0001607062-21-000518 |
| Sep 28, 2021 | 8-K | 0001607062-21-000363 |
| Aug 6, 2021 | 10-Q | 0001607062-21-000259 |
| Aug 2, 2021 | 4 | 0001607062-21-000244 |
| Jul 2, 2021 | EFFECT | 9999999995-21-002633 |
| Jun 23, 2021 | POS AM | 0001607062-21-000174 |
| May 13, 2021 | 10-Q | 0001607062-21-000117 |
| Mar 30, 2021 | 10-K | 0001607062-21-000063 |
| Mar 18, 2021 | 4/A | 0001607062-21-000058 |
| Mar 18, 2021 | 4/A | 0001607062-21-000059 |
| Mar 17, 2021 | 8-K | 0001607062-21-000057 |
| Mar 16, 2021 | 4 | 0001607062-21-000050 |
| Mar 16, 2021 | 4 | 0001607062-21-000054 |
| Mar 16, 2021 | 4 | 0001607062-21-000053 |